Newbridge Financial Services Group’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26
| Closed | -$82 | – | 1385 |
|
|
2025
Q1 | $82 | Sell |
26
-2
| -7% | -$6 | ﹤0.01% | 1016 |
|
|
2024
Q4 | $187 | Hold |
28
| – | – | ﹤0.01% | 1090 |
|
|
2024
Q3 | $342 | Hold |
28
| – | – | ﹤0.01% | 620 |
|
|
2024
Q2 | $631 | Hold |
28
| – | – | ﹤0.01% | 1013 |
|
|
2024
Q1 | $1.38K | Hold |
28
| – | – | ﹤0.01% | 1026 |
|
|
2023
Q4 | $2.11K | Hold |
28
| – | – | ﹤0.01% | 962 |
|
|
2023
Q3 | $2.33K | Sell |
28
-4
| -13% | -$333 | ﹤0.01% | 1055 |
|
|
2023
Q2 | $4.48K | Hold |
32
| – | – | ﹤0.01% | 1027 |
|
|
2023
Q1 | $9.28K | Hold |
32
| – | – | ﹤0.01% | 923 |
|
|
2022
Q4 | $8.41K | Hold |
32
| – | – | ﹤0.01% | 948 |
|
|
2022
Q3 | $9K | Hold |
32
| – | – | 0.01% | 920 |
|
|
2022
Q2 | $11K | Hold |
32
| – | – | 0.01% | 850 |
|
|
2022
Q1 | $20K | Hold |
32
| – | – | 0.01% | 738 |
|
|
2021
Q4 | $20K | Hold |
32
| – | – | 0.01% | 737 |
|
|
2021
Q3 | $32K | Hold |
32
| – | – | 0.02% | 542 |
|
|
2021
Q2 | $48K | Hold |
32
| – | – | 0.03% | 455 |
|
|
2021
Q1 | $87K | Hold |
32
| – | – | 0.06% | 281 |
|
|
2020
Q4 | $64K | Buy |
32
+11
| +52% | +$22K | 0.05% | 283 |
|
|
2020
Q3 | $57K | Buy |
+21
| New | +$57K | 0.06% | 298 |
|